Home > National Drug Code (NDC) > METHOTREXATE

METHOTREXATE - 0703-3671-03 - (methotrexate sodium)

Alphabetical Index


Drug Information of METHOTREXATE

Product NDC: 0703-3671
Proprietary Name: METHOTREXATE
Non Proprietary Name: methotrexate sodium
Active Ingredient(s): 25    mg/mL & nbsp;   methotrexate sodium
Administration Route(s): INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of METHOTREXATE

Product NDC: 0703-3671
Labeler Name: Teva Parenteral Medicines, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA040850
Marketing Category: ANDA
Start Marketing Date: 20120731

Package Information of METHOTREXATE

Package NDC: 0703-3671-03
Package Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (0703-3671-03) > 2 mL in 1 VIAL, SINGLE-DOSE (0703-3671-01)

NDC Information of METHOTREXATE

NDC Code 0703-3671-03
Proprietary Name METHOTREXATE
Package Description 10 VIAL, SINGLE-DOSE in 1 CARTON (0703-3671-03) > 2 mL in 1 VIAL, SINGLE-DOSE (0703-3671-01)
Product NDC 0703-3671
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name methotrexate sodium
Dosage Form Name INJECTION, SOLUTION
Route Name INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Start Marketing Date 20120731
Marketing Category Name ANDA
Labeler Name Teva Parenteral Medicines, Inc.
Substance Name METHOTREXATE SODIUM
Strength Number 25
Strength Unit mg/mL
Pharmaceutical Classes Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]

Complete Information of METHOTREXATE


General Information